Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lorente

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
European Urology|August 10, 2021
Prognostic Score and Benefit from Abiraterone in First-line Metastatic, Castration-resistant Prostate CancerDavid Lorente, Casilda Llacer, Rebeca Lozano, et al.
Melanoma Research|June 16, 2026
Melanocortin-1 receptor variants and telomerase reverse transcriptase promoter mutations as prognostic biomarkers in stage IIB-IIC melanomaMarcella Scala, David Lorente-Estellés, Luigi Liguori, et al.
Medical Oncology (Northwood, London, England)|April 18, 2014
Safety and efficacy of sorafenib in the treatment of advanced hepatocellular carcinoma: a single center experienceEsteban Rodrigo Imedio, Roberto Díaz Beveridge, Jorge Aparicio Urtasun, et al.
BMC Geriatrics|September 5, 2022
Dignity and psychosocial related variables in elderly advanced cancer patientsCarla M Martín-Abreu, Raquel Hernández, Patricia Cruz-Castellanos, et al.
Radiology|January 26, 2016
Volume of Bone Metastasis Assessed with Whole-Body Diffusion-weighted Imaging Is Associated with Overall Survival in Metastatic Castration-resistant Prostate CancerRaquel Perez-Lopez, David Lorente, Matthew D Blackledge, et al.
The Oncologist|January 25, 2021
Impact of Obesity on Quality of Life, Psychological Distress, and Coping on Patients with Colon CancerDavid Gomez, Paula Jimenez-Fonseca, Aránzazu Manzano Fernández, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 29, 2023
Impact of systemic cancer treatment on quality of life and mental well-being: a comparative analysis of patients with localized and advanced cancerAdán Rodríguez-Gonzalez, Alberto Carmona-Bayonas, Raquel Hernandez San Gil, et al.
British Journal of Cancer|May 17, 2018
Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancersJorge Cortes, Kenji Tamura, Daniel J DeAngelo, et al.
Science Translational Medicine|September 19, 2014
Tumor clone dynamics in lethal prostate cancerSuzanne Carreira, Alessandro Romanel, Jane Goodall, et al.
European Urology Focus|July 30, 2017
Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional SurveyDavid Lorente, Praful Ravi, Niven Mehra, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
European Urology|August 10, 2021
Prognostic Score and Benefit from Abiraterone in First-line Metastatic, Castration-resistant Prostate CancerDavid Lorente, Casilda Llacer, Rebeca Lozano, et al.
Melanoma Research|June 16, 2026
Melanocortin-1 receptor variants and telomerase reverse transcriptase promoter mutations as prognostic biomarkers in stage IIB-IIC melanomaMarcella Scala, David Lorente-Estellés, Luigi Liguori, et al.
Medical Oncology (Northwood, London, England)|April 18, 2014
Safety and efficacy of sorafenib in the treatment of advanced hepatocellular carcinoma: a single center experienceEsteban Rodrigo Imedio, Roberto Díaz Beveridge, Jorge Aparicio Urtasun, et al.
BMC Geriatrics|September 5, 2022
Dignity and psychosocial related variables in elderly advanced cancer patientsCarla M Martín-Abreu, Raquel Hernández, Patricia Cruz-Castellanos, et al.
Radiology|January 26, 2016
Volume of Bone Metastasis Assessed with Whole-Body Diffusion-weighted Imaging Is Associated with Overall Survival in Metastatic Castration-resistant Prostate CancerRaquel Perez-Lopez, David Lorente, Matthew D Blackledge, et al.
The Oncologist|January 25, 2021
Impact of Obesity on Quality of Life, Psychological Distress, and Coping on Patients with Colon CancerDavid Gomez, Paula Jimenez-Fonseca, Aránzazu Manzano Fernández, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 29, 2023
Impact of systemic cancer treatment on quality of life and mental well-being: a comparative analysis of patients with localized and advanced cancerAdán Rodríguez-Gonzalez, Alberto Carmona-Bayonas, Raquel Hernandez San Gil, et al.
British Journal of Cancer|May 17, 2018
Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancersJorge Cortes, Kenji Tamura, Daniel J DeAngelo, et al.
Science Translational Medicine|September 19, 2014
Tumor clone dynamics in lethal prostate cancerSuzanne Carreira, Alessandro Romanel, Jane Goodall, et al.
European Urology Focus|July 30, 2017
Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional SurveyDavid Lorente, Praful Ravi, Niven Mehra, et al.
Pageof 8